Part 1 of 2: Beyond depression: Evaluation of newer indications and off-label uses for SSRIs

Formulary

Volumn 37, Issue 5, 2002, Pages 240-251

  Lee, Kelly C ^a   Feldman, Mitchell D ^a   Finley, Patrick R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; CHLORPHENIRAMINE; CHLORPROMAZINE; CITALOPRAM; CLOZAPINE; DESIPRAMINE; DEXTROMETHORPHAN; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; HALOPERIDOL; IMIPRAMINE; METOPROLOL; NEFAZODONE; NONSTEROID ANTIINFLAMMATORY AGENT; PAROXETINE; PHENYTOIN; PROPRANOLOL; PROZAC WEEKLY; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TACRINE; THEOPHYLLINE; TIOTIXENE; TOLBUTAMIDE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE; WARFARIN; ZOLPIDEM;

ANTICHOLINERGIC EFFECT; ANXIETY NEUROSIS; BULIMIA; CLINICAL TRIAL; DEPRESSION; DRUG CHOICE; DRUG FORMULATION; DRUG INDICATION; DRUG MECHANISM; GASTROINTESTINAL TOXICITY; HUMAN; INSOMNIA; MENTAL DISEASE; OBSESSION; PANIC; POSTTRAUMATIC STRESS DISORDER; PREMENSTRUAL DYSPHORIC DISORDER; REVIEW; SEXUAL DYSFUNCTION; SOCIAL PHOBIA; SOMNOLENCE; WEIGHT GAIN;

EID: 0036244228     PISSN: 1082801X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Selective serotonin-reuptake inhibitors: An update
2. New indications for antidepressants
3. Drug Facts and Comparisons
4. Mood disorders I: Major depressive disorders
5. Strategies for treatment of generalized anxiety in the primary care setting
6. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey
7. Generalized anxiety disorder
8. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline
9. Paroxetine is effective in the treatment of generalized anxiety disorder: Results from a randomized placebo-controlled flexible dose study
10. Paroxetine treatment of GAD: A double-blind, placebo-controlled trial
11. Algorithms for the diagnosis and management of anxiety disorders in the primary care setting
12. Evidence of the dual mechanisms of action of venlafaxine
13. Pharmacology of antidepressants
14. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial
15. Phenomenology and course of generalised anxiety disorder
16. A treatment algorithm for the management of anxiety in primary care practice
17. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder
18. The epidemiology of obsessive-compulsive disorder in five US communities
19. Obsessive-compulsive and spectrum disorders: Overview and quality of life issues
20. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: Comparison of fluvoxamine and desipramine
21. Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder
22. Managing the patient with treatment resistant obsessive-compulsive disorder: Current strategies
23. Pharmacology of antidepressants
24. Treatment of obsessive-compulsive disorder
25. Panic: Course, complications and treatment of panic disorder
26. Current concepts in the treatment of panic disorder
27. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder
28. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder
29. Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder
30. Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study
31. Do selective serotonin re-uptake inhibitors enhance the efficacy of very brief cognitive behavioral therapy for panic disorder? A pilot study
32. Sertraline in the treatment of panic disorder: A double-blind multicenter trial
33. Sertraline in the treatment of panic disorder: A flexible-dose multicenter trial
34. Sertraline in the treatment of panic disorder. A multisite, double-blind, placebo-controlled, fixed-dose investigation
35. Effect of fluvoxamine on panic disorder
36. Fluvoxamine in the treatment of panic disorder: A multi-center, double-blind, placebo-controlled study in outpatients
37. A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder
38. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia
39. Serotonin function in panic disorder: A double blind placebo controlled study with fluvoxamine and ritanserin
40. The effect of citalopram in panic disorder
41. A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder
42. Moclobemide and fluoxetine for panic disorder
43. Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety
44. Posttraumatic stress disorder in the National Comorbidity Survey
45. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: A randomized controlled trial
46. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder
47. Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: Results of a 28-week double-blind, placebo-controlled study
48. Posttraumatic stress disorder and quality of life: Results across 64 weeks of sertraline treatment
49. Efficacy and safety of paroxetine treatment for chronic PTSD: A fixed-dose, placebo-controlled study
50. Paroxetine in the treatment of chronic posttraumatic stress disorder: Results of a placebo-controlled, flexible-dosage trial
51. Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study
52. Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder
53. Fluvoxamine treatment for chronic PTSD: A pilot study
54. The clinical experience of citalopram in the treatment of post-traumatic stress disorder: A report of two Persian Gulf War veterans
55. Open trial of citalopram in adults with post-traumatic stress disorder
56. Management of posttraumatic stress disorder: Diagnostic and therapeutic issues
57. Social phobia in the general population: Prevalence and sociodemographic profile
58. Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey
59. Paroxetine treatment of generalized social phobia (social anxiety disorder): A randomized controlled trial
60. Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study
61. Paroxetine in social anxiety disorder: A randomized placebo-controlled study
62. A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder
63. Psychopharmacological treatment of social phobia: A double blind placebo controlled study with fluvoxamine
64. Fluvoxamine treatment of social phobia (social anxiety disorder): A double-blind, placebo-controlled study
65. Sertraline for social phobia: A double-blind, placebocontrolled crossover study
66. Sertraline in the treatment of anxiety disorders
67. Selective serotonin-reuptake inhibitors: An update
68. The efficacy of the selective serotonin reuptake inhibitors for social anxiety disorder (social phobia): A meta-analysis of randomized controlled trials
69. Treatment of social phobia with antidepressants